Shots:

• EMA’s COMP has granted ODD to SLS-005 for the treatment of amyotrophic lateral sclerosis
• Under ODD- Seelos will get benefit from several incentives such as protocol assistance- reduced regulatory fees and market exclusivity
• Trehalose is a low molecular weight disaccharide (0.342 kDa) that crosses the BBB- stabilizes proteins and activates autophagy and has received the US FDA’s ODD in Nov’2020

  Ref: PRNewswire | Image: PRNewswire